SQSTM1 and cardiac hypertrophy: In the current study we demonstrated that subpressor Ang II and diabetes additively elicited cardiac hypertrophy along with increased cardiac miR-221 and inhibition of autophagosome-lysosome pathway, as evidenced by the decrease of LC3-II level and the increase of p62 level.